Back to Search
JOSEPH MATTERN, M.D.
Family Medicine Physician
NPI: 1023060423IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD00042614(WA)
Education
OTHER
Class of 2000
Research & Publications (20)
CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
PMID 19676044·Int J Cancer·2010
7-preclinical
Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance.
PMID 19118495·BMC Syst Biol·2009
8-other
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.
PMID 18829980·Gut·2009
7-preclinical
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
PMID 19506160·J Clin Oncol·2009
3-trial
Glucocorticoid-mediated apoptosis resistance of solid tumors.
PMID 19132324·Results Probl Cell Differ·2009
6-review
Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer.
PMID 18202717·Cancer Gene Ther·2008
7-preclinical
Prediction of broad spectrum resistance of tumors towards anticancer drugs.
PMID 18413831·Clin Cancer Res·2008
8-other
BrainIT collaborative network: analyses from a high time-resolution dataset of head injured patients.
PMID 19388320·Acta Neurochir Suppl·2008
8-other
The brain monitoring with Information Technology (BrainIT) collaborative network: data validation results.
PMID 19388319·Acta Neurochir Suppl·2008
4-observational
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.
PMID 18665180·Br J Cancer·2008
7-preclinical
The use of hyperventilation therapy after traumatic brain injury in Europe: an analysis of the BrainIT database.
PMID 18449528·Intensive Care Med·2008
8-other
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.
PMID 17224649·Cancer Biol Ther·2007
7-preclinical
Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy.
PMID 18087223·Cancer Biol Ther·2007
6-review
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects.
PMID 17186015·Cancer Gene Ther·2007
7-preclinical
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy.
PMID 16338063·Cancer Lett·2006
7-preclinical
Corticosteroid-induced chemotherapy resistance in urological cancers.
PMID 16294015·Cancer Biol Ther·2006
8-other
Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.
PMID 16391812·Int J Oncol·2006
7-preclinical
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
PMID 16470224·Cell Death Differ·2006
8-other
Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.
PMID 16539710·BMC Cancer·2006
7-preclinical
Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.
PMID 15756274·Br J Cancer·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 915 SHERIDAN ST, SUITE B103
PORT TOWNSEND, WA 98368 - Phone
- (360) 379-8031
Quick Facts
- NPI
- 1023060423
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile